A91 Partners
A91 Partners is a growth-stage India investor built around a team-led model rather than a single-partner franchise. Its portfolio spans consumer brands, financial services, healthcare, technology and durable businesses serving India’s expanding middle class.
At a glance
- Founded
- 2018
- Footprint
- Mumbai
- Stage
- Growth (Series B-D)
Research profile
Read the manager in sequence.
Open a section to inspect the evidence. The first view starts with the investment point of view; the rest stays quiet until you need it.
Investment lens
A91 Partners uses a growth (series b-d) approach across Consumer, healthcare, fintech, tech.
Current evidence
A91 closed Fund III at $665M, with IFC separately disclosing a proposed commitment and co-investment envelope; public reporting names Digit Insurance, Blue Tokai, Atomberg, SUGAR Cosmetics and other positions.
Bundled fund series
Related manager and vehicle records are shown here as one fund family. The original source trails and vehicle-level caveats remain preserved in the research record.
A91 Partners Fund 3
Vintage / record year: 2025
Strategy
Growth (Series B-D)
Sector focus
Consumer, healthcare, fintech, tech
Current signal
A91 closed Fund III at $665M, with IFC separately disclosing a proposed commitment and co-investment envelope; public reporting names Digit Insurance, Blue Tokai, Atomberg, SUGAR Cosmetics and other positions.
Next step
Need this manager reviewed against your mandate?
Share the allocation question, ticket size, liquidity constraints and existing exposure. Rupeia can determine whether this profile needs a deeper decision-support brief.